Evaluations of thyme extract effects in human normal bronchial and tracheal epithelial cell lines and in human lung cancer cell line

Chemico-Biological Interactions

Volumn 256, Issue , 2016, Pages 125-133

  Oliviero, Marinelli ^a   Romilde, Iannarelli ^a   Beatrice, Morelli Maria ^b   Matteo, Valisi ^c   Giovanna, Nicotra ^c   Consuelo, Amantini ^d   Claudio, Cardinali ^b   Giorgio, Santoni ^a   Maggi, Filippo ^a   Massimo, Nabissi ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Superchrom Srl   (Italy)

^d School of Biosciences and Biotechnologies   (Italy)

Author keywords

Anti inflammatory; Lung cancer; NF B; Normal bronchial and tracheal epithelial cells (HBEpC HTEpC); Thymol; Thymus vulgaris

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; MUCIN 5AC; PLANT EXTRACT; THYMUS VULGARIS EXTRACT; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; THYMOL;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DRUG MECHANISM; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN SECRETION; THYME; BRONCHUS; CELL DEATH; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; IMMUNOLOGY; LUNG; LUNG NEOPLASMS; RESPIRATORY MUCOSA; THYMUS (PLANT); TRACHEA; TUMOR CELL LINE;

ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BRONCHI; CELL DEATH; CELL LINE; CELL LINE, TUMOR; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-8; LUNG; LUNG NEOPLASMS; NF-KAPPA B; PLANT EXTRACTS; RESPIRATORY MUCOSA; THYMOL; THYMUS PLANT; TRACHEA;

EID: 84978153799     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2016.06.024     Document Type: Article

References (50)

1. [1] Weigand, L.A., Undem, B.J., Allergen-induced neuromodulation in the respiratory tract. Chem. Immunol. Allergy 98 (2012), 142–162.
2. [2] Gould, H.J., Sutton, B.J., IgE in allergy and asthma today. Nat. Rev. Immunol. 8:3 (2008), 205–217.
3. [3] Barnes, P.J., Immunology of asthma and chronic obstructive pulmonary disease. Nat. Rev. Immunol. 8:3 (2008), 183–192.
4. [4] Holgate, S.T., Epithelium dysfunction in asthma. Dec J. Allergy Clin. Immunol. 120:6 (2007), 1233–1244 quiz 1245–6.
5. [5] Rhen, T., Cidlowski, J.A., Antiinflammatory action of glucocorticoids—new mechanisms for old drugs. N. Engl. J. Med. 353:16 (2005), 1711–1723.
6. [6] WHO Regional Office for the Western Pacific, Research Guidelines for Evaluating the Safety and Efficacy of Herbal Medicine. 1993 Manila, Republic of the Philippines.
7. [7] Nabavi, S.M., Marchese, A., Izadi, M., Curti, V., Daglia, M., Nabavi, S.F., Plants belonging to the genus Thymus as antibacterial agents: from farm to pharmacy. Food Chem. 173 (2015), 339–347.
8. [8] Rasooli, I., Mirmostafa, S.A., Antibacterial properties of Thymus pubescens and Thymus serpyllum essential oils. Fitoterapia 73 (2002), 244–250.
9. [9] Tepe, B., Daferera, D., Sökmen, M., Polissiou, M., Sökmen, A., In vitro antimicrobial and antioxidant activities of the essential oils and various extracts of Thymus eigii M. Zohary et P.H. Davis. J. Agric. Food Chem. 52 (2004), 1132–1137.
10. [10] Vanaclocha, B., Cañigueral, S., Fitoterapia: Vademecum de Prescripción. 4th ed., 2003, Masson Ed., Barcelona, Spain.
11. [11] Al-Bayati, F.A., Synergistic antibacterial activity between Thymus vulgaris and Pimpinella anisum essential oils and methanol extracts. J. Ethnopharmacol. 116 (2008), 403–406.
12. [12] Allen, D.A., Hatfield, G., Medicinal Plants in Folk Tradition. An Ethnobotany of Britain and Ireland. 2004, Timber Press, Inc, Portland, Oregon, USA.
13. [13] Alonso, J.R., Tratado de Fitomedicina. Bases Clınicas y Farmacologicas. 1998, Isis Ediciones, Buenos Aires, Argentina.
14. [14] Martins, N., Barros, L., Santos-Buelga, C., Silva, S., Henriques, M., Ferreira, I.C.F.R., Decoction, infusion and hydroalcoholic extract of cultivated thyme: antioxidant and antibacterial activities, and phenolic characterisation. Food Chem. 167 (2015), 131–137.
15. [15] Cheng, D.S., Han, W., Chen, S.M., Sherrill, T.P., Chont, M., Park, G.Y., Sheller, J.R., Polosukhin, V.V., Christman, J.W., Yull, F.E., Blackwell, T.S., Airway epithelium controls lung inflammation and injury through the NF-kappa B pathway. J. Immunol. 178 (2007), 6504–6513.
16. [16] Li, J.D., Dohrman, A.F., Gallup, M., Miyata, S., Gum, J.R., Kim, Y.S., Nadel, J.A., Prince, A., Basbaum, C.B., Transcriptional activation of mucin by Pseudomonas aeruginosa lipopolysaccharide in the pathogenesis of cystic fibrosis lung disease. Proc. Natl. Acad. Sci. U.S.A. 94 (1997), 967–972.
17. [17] Kohri, K., Ueki, I.F., Shim, J.J., Burgel, P.R., Oh, Y.M., Tam, D.C., Dao-Pick, T., Nadel, J.A., Pseudomonas aeruginosa induces Muc5ac production via epidermal growth factor receptor. Eur. Respir. J. 20 (2002), 1263–1270.
18. [18] Vendramini-Costa, D.B., Carvalho, J.E., Molecular link mechanisms between inflammation and cancer. Curr. Pharm. Des. 18 (2012), 3831–3852.
19. [19] Kang, J.H., Hwang, S.M., Chung, I.Y., S100A8, S100A9 and S100A12 activate airway epithelial cells to produce MUC5AC via extracellular signal-regulated kinase and nuclear factor-κB pathways. Immunology 144:1 (2015), 79–90.
20. [20] Soliman, K.M., Badeaa, R.I., Effect of oil extracted from some medicinal plants on different mycotoxigenic fungi. Food Chem. Toxicol. 40:11 (2002), 1669–1675.
21. [21] Bukovská, A., Cikos, S., Juhás, S., Il'ková, G., Rehák, P., Koppel, J., Effects of a combination of thyme and oregano essential oils on TNBS-induced colitis in mice. Mediat. Inflamm., 2007, 23296, 10.1155/2007/23296.
22. [22] Begrow, F., Engelbertz, J., Feistel, B., Lehnfeld, R., Bauer, K., Verspohl, E.J., Impact of thymol in thyme extracts on their antispasmodic action and ciliary clearance. Planta Med. 76 (2010), 311–318.
23. [23] Vigo, E., Cepeda, A., Gualillo, O., Perez-Fernandez, R., In-vitro anti-inflammatory effect of Eucalyptus globulus and Thymus vulgaris: nitric oxide inhibition in J774A.1 murine macrophages. J. Pharm. Pharmacol. 56 (2004), 257–263.
24. [24] Ocaña, A., Reglero, G., Effects of thyme extract oils (from Thymus vulgaris, Thymus zygis, and Thymus hyemalis) on cytokine production and gene expression of oxldl-stimulated thp-1-macrophages. J. Obes., 2012, 104706.
25. [25] Braga, P.C., Dal Sasso, M., Culici, M., Bianchi, T., Bordoni, L., Marabini, L., Anti-inflammatory activity of thymol: inhibitory effect on the release of human neutrophil elastase. Pharmacology 77 (2006), 130–136.
26. [26] Suzuki, Y., Furuta, H., Stimulation of guinea pig neutrophil superoxide anion-producing system with thymol. Inflammation 12 (1988), 575–584.
27. [27] Aeschbach, R., Löliger, J., Scott, B.C., Murcia, A., Butler, J., Halliwell, B., Aruoma, O.I., Antioxidant actions of thymol, carvacrol, 6-gingerol, zingerone and hydroxytyrosol. Food Chem. Toxicol. 32 (1994), 31–36.
28. [28] Didry, N., Dubreuil, L., Pinkas, M., Activity of thymol, carvacrol, cinnamaldehyde and eugenol on oral bacteria. Pharm. Acta Helv. 69 (1994), 25–28.
29. [29] Segvić Klarić, M., Kosalec, I., Mastelić, J., Piecková, E., Pepeljnak, S., Antifungal activity of thyme (Thymus vulgaris L.) essential oil and thymol against moulds from damp dwellings. Lett. Appl. Microbiol. 44 (2007), 36–42.
30. [30] Fujisawa, S., Kadoma, Y., Effect of phenolic compounds on the polymerization of methyl methacrylate. Dent. Mater 8 (1992), 324–326.
31. [31] Jeffery, P., Zhu, J., Mucin-producing elements and inflammatory cells. Novartis Found. Symp. 248 (2002), 51–68 discussion 68-75, 277-282.
32. [32] Dinarello, C.A., Interleukin-1. Cytokine Growth Factor Rev. 8 (1997), 253–265.
33. [33] Kadota, J., Matsubara, Y., Ishimatsu, Y., Ashida, M., Abe, K., Shirai, R., Iida, K., Kawakami, K., Taniguchi, H., Fujii, T., Kaseda, M., Kawamoto, S., Kohno, S., Significance of IL-1beta and IL-1 receptor antagonist (IL-1Ra) in bronchoalveolar lavage fluid (BALF) in patients with diffuse panbronchiolitis (DPB). Clin. Exp. Immunol. 103 (1996), 461–466.
34. [34] Thornton, D.J., Rousseau, K., McGuckin, M.A., Structure and function of the polymeric mucins in airways mucus. Ann. Rev. Physiol. 70 (2008), 459–486.
35. [35] Randell, S.H., Boucher, R.C., Effective mucus clearance is essential for respiratory health. Am. J. Resp. Cell. Mol. Biol. 35 (2006), 20–28.
36. [36] Rose, M.C., Voynow, J.A., Respiratory tract mucin genes and glycoproteins in health and disease. Physiol. Rev. 86 (2006), 245–278.
37. [37] Kirkham, S., Sheehan, J.K., Knight, D., Richardson, P.S., Thornton, D.J., Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B. Biochem J. 361 (2002), 537–546.
38. [38] Basbaum, C., Lemjabbar, H., Longphre, M., Li, D., Gensch, E., McNamara, N., Control of mucin transcription by diverse injury-induced signaling pathways. Am. J. Respir. Crit. Care Med. 160 (1999), S44–S48.
39. [39] Li, D., Gallup, M., Fan, N., Szymkowski, D.E., Basbaum, C.B., Cloning of the amino-terminal and 5’-flanking region of the human MUC5AC mucin gene and transcriptional up-regulation by bacterial exoproducts. J. Biol. Chem. 273 (1998), 6812–6820.
40. [40] Longphre, M., Li, D., Gallup, M., Drori, E., Ordoñez, C.L., Redman, T., Wenzel, S., Bice, D.E., Fahy, J.V., Basbaum, C., Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells. J. Clin. Invest. 104 (1999), 1375–1382.
41. [41] Koo, J.S., Kim, Y.D., Jetten, A.M., Belloni, P., Nettesheim, P., Overexpression of mucin genes induced by interleukin-1 beta, tumor necrosis factor-alpha, lipopolysaccharide, and neutrophil elastase is inhibited by a retinoic acid receptor alpha antagonist. Exp. Lung Res. 28 (2002), 315–332.
42. [42] Song, K.S., Lee, W.J., Chung, K.C., Koo, J.S., Yang, E.J., Choi, J.Y., Yoon, J.H., Interleukin-1 beta and tumor necrosis factor-alpha induce MUC5AC overexpression through a mechanism involving ERK/p38 mitogen-activated protein kinases-MSK1-CREB activation in human airway epithelial cells. J. Biol. Chem. 278 (2003), 23243–23250.
43. [43] Lawrence, T., The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb. Perspect. Biol., 1(6), 2009.
44. [44] Weih DS, Yilmaz ZB, Weih F. 2001. Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. 67(4):1909–1919.
45. [45] Saxon, J.A., Cheng, D.S., Han, W., Polosukhin, V.V., McLoed, A.G., Richmond, B.W., Gleaves, L.A., Tanjore, H., Sherrill, T.P., Barham, W., Yull, F.E., Blackwell, T.S., p52 overexpression increases epithelial apoptosis, enhances lung injury, and reduces survival after lipopolysaccharide treatment. J. Immunol. 196:4 (2016), 1891–1899.
46. [46] Lewis, A.M., Varghese, S., Xu, H., Alexander, H.R., Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J. Transl. Med., 4, 2006, 48.
47. [47] Waugh, D.J., Wilson, C., The interleukin-8 pathway in cancer. Clin. Cancer Res. 14 (2008), 6735–6741.
48. [48] Chen, W., Wang, X., Bai, L., Liang, X., Zhuang, J., Lin, Y., Blockage of NF-kappaB by IKKbeta- or RelA-siRNA rather than the NF-kappaB super-suppressor IkappaBalpha mutant potentiates adriamycin-induced cytotoxicity in lung cancer cells. J. Cell Biochem. 105:2 (2008), 554–561.
49. [49] Hur, G.M., Lewis, J., Yang, Q., Lin, Y., Nakano, H., Nedospasov, S., Liu, Z.G., The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation. Genes Dev. 17:7 (2003), 873–882.
50. [50] Elaraj, D.M., Weinreich, D.M., Varghese, S., Puhlmann, M., Hewitt, S.M., Carroll, N.M., Feldman, E.D., Turner, E.M., Alexander, H.R., The role of interleukin 1 in growth and metastasis of human cancer xenografts. Clin. Cancer Res. 12:4 (2006), 1088–1096.